AI in Medical Diagnostics Market Research Report Information By Component (Software, Hardware, and Services), By Application (In Vivo Diagnostics and In Vitro Diagnostics), By End User (Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT

6.1. Overview

6.2. Software

6.3. Hardware

6.4. Services

7. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION

7.1. Overview

7.2. In Vivo Diagnostics

7.3. In Vitro Diagnostics

8. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER

8.1. Overview

8.2. Hospitals

8.3. Diagnostic Imaging Centers

8.4. Diagnostic Laboratories

8.5. Others

9. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global AI in Medical Diagnostics Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global AI in Medical Diagnostics Market,

10.7. Key Developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Siemens Healthineers

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Vuno, Inc.

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Nanox Imaging LTD (Zebra Medical Vision, Inc.)

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Riverain Technologies

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Aidoc

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. AliveCor Inc.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Neural Analytics

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Digital Diagnostics, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Imagen Technologies

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. GE Healthcare

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Enlitic

11.11.1. Company Overview

11.11.2. Financial Overview

11.11.3. Products Offered

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. InformAI

11.12.1. Company Overview

11.12.2. Financial Overview

11.12.3. Products Offered

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 9 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 10 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 11 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 12 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 13 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 10 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 11 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 16 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 17 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 28 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 29 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 30 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 31 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 32 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 33 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET

FIGURE 4 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY COMPONENT, 2023

FIGURE 5 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 6 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY END USER, 2023

FIGURE 7 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 SIEMENS HEALTHINEERS: SWOT ANALYSIS

FIGURE 15 VUNO, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 VUNO, INC.: SWOT ANALYSIS

FIGURE 17 NANOX IMAGING LTD (ZEBRA MEDICAL VISION, INC.): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 NANOX IMAGING LTD (ZEBRA MEDICAL VISION, INC.): SWOT ANALYSIS

FIGURE 19 RIVERAIN TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 RIVERAIN TECHNOLOGIES: SWOT ANALYSIS

FIGURE 21 AIDOC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 AIDOC: SWOT ANALYSIS

FIGURE 23 ALIVECOR INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 ALIVECOR INC.: SWOT ANALYSIS

FIGURE 25 NEURAL ANALYTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 NEURAL ANALYTICS: SWOT ANALYSIS

FIGURE 27 DIGITAL DIAGNOSTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 DIGITAL DIAGNOSTICS, INC.: SWOT ANALYSIS

FIGURE 29 IMAGEN TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 IMAGEN TECHNOLOGIES: SWOT ANALYSIS

FIGURE 31 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 GE HEALTHCARE: SWOT ANALYSIS

FIGURE 33 ENLITIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ENLITIC: SWOT ANALYSIS

FIGURE 35 INFORMAI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 INFORMAI: SWOT ANALYSIS